ALPS Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-128,068
| Closed | -$5.41M | – | 1010 |
|
|
2024
Q1 | $5.41M | Buy |
128,068
+30,379
| +31% | +$1.28M | 0.04% | 230 |
|
|
2023
Q4 | $4.14M | Sell |
97,689
-18,574
| -16% | -$788K | 0.03% | 238 |
|
|
2023
Q3 | $2.54M | Buy |
116,263
+984
| +0.9% | +$21.5K | 0.02% | 288 |
|
|
2023
Q2 | $3.66M | Buy |
115,279
+12,069
| +12% | +$384K | 0.03% | 220 |
|
|
2023
Q1 | $2.52M | Sell |
103,210
-2,856
| -3% | -$69.7K | 0.02% | 249 |
|
|
2022
Q4 | $3.35M | Buy |
106,066
+21,096
| +25% | +$665K | 0.03% | 220 |
|
|
2022
Q3 | $2.4M | Sell |
84,970
-2,999
| -3% | -$84.7K | 0.02% | 276 |
|
|
2022
Q2 | $2.33M | Sell |
87,969
-64,146
| -42% | -$1.7M | 0.02% | 290 |
|
|
2022
Q1 | $5.33M | Sell |
152,115
-18,284
| -11% | -$640K | 0.06% | 128 |
|
|
2021
Q4 | $5.52M | Sell |
170,399
-7,166
| -4% | -$232K | 0.06% | 143 |
|
|
2021
Q3 | $5.24M | Buy |
177,565
+10,582
| +6% | +$312K | 0.05% | 171 |
|
|
2021
Q2 | $4.28M | Buy |
+166,983
| New | +$4.28M | 0.04% | 184 |
|